2Chatteriee S. Permanent hypoparathyroidism following radioiodine treatment for hyperthyroidism[J]. J Assoc Physicianslndia, 2004, 52(5):421.
3Vannucchi G, Campi I, Covelli D, et al. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis[J]. J Clin Endocrinol Metab, 2009, 94(9) : 3 381.
4Pauwels EKJ, Smit JWA, Slats A, et al. Health effects of therapeutic use of ^131I in hyperthyroidism[J]. Quart Nuc JMed,2000, 44(4): 333.
5Rivkees SA, Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children [J]. Pediatrics, 2003, 111 (4) : 745.
6潘中允主编.临床核医学[M].第2版.北京:原子能出版社,1999:533-543.
7Gamstedt A, Wadman B , Karlsson A. Methimazole, but not betamethasone, prevents ^131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease[J]. The Journal of Clinical Endocrinology and Metabolism, 1985,62 (4) : 773.
8Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study[J].The Journal of Clinical Endocrinology and Metabolism, 2001,86 (8) : 3 488.
9Abraham P, Avenell A, Watson WA, et al.Antithyroid drug regimen for treating Graves' hyperthyroidism[J]. Cochrane Database Syst Rev, 2005,18 ( 2 ) : 3 420.
10Hancock LD, Tuttle RM, LeMar H, et al. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease[J].Clin Endocrinol (Oxf) , 1997, 47 (4):425.
